家禽疫苗市场概况、增长、趋势、分析、研究报告(2023-2031 年)

  • Report Code : TIPRE00004772
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 233
Buy Now

Poultry Vaccines Market Report - (Growth and Size by 2031)

Buy Now

家禽疫苗市场规模预计将从 2023 年的 21 亿美元增至 2031 年的 41 亿美元。预计 2023-2031 年市场复合年增长率将达到8.6%。载体疫苗和联合疫苗的进步可能仍是家禽疫苗市场的主要趋势。

家禽疫苗市场分析

家禽疾病发病率上升

家禽生产通过鸡蛋和肉类产生不同类型的动物蛋白。随着家禽产量的增加,感染多种 人畜共患疾病(如“禽病”)的可能性很高,这可能导致巨大的经济损失,尤其是在发展中国家。例如,鸡更容易感染细菌、病毒、寄生虫和真菌这些病毒爆发可能导致各种家禽感染新城疫、禽流感、传染性法氏囊病和其他疾病。

下表列出了 2022 年多个国家哺乳动物禽流感疾病爆发情况。

哺乳动物禽流感病例

国家

家禽疾病

疾病爆发(2022 年)

阿根廷

H5

18

智利

三十四

挪威

2

乌拉圭

3

秘鲁

12

   

巴西

禽流感病毒

5

加拿大

40

中国

1

爱沙尼亚

1

芬兰

76

法国

2

爱尔兰

2

意大利

3

日本

4

俄罗斯

1

   

加拿大

禽流感病毒

2

   

丹麦

禽流感病毒

1

来源:世界动物卫生组织 2023

家禽疾病是导致雏鸡死亡的主要原因,也会导致牲畜数量减少。由于传播人畜共患疾病,给哺乳动物的健康带来严重威胁,农民面临着巨大的经济损失。例如,家禽球虫病是全​​球最常见的疾病之一;它会导致与死亡、体重减轻以及与预防和治疗控制相关的额外费用相关的巨大损失。根据 DSM 公司网站的数据,全球农民每年因鸡和禽类球虫病而面临 30 亿美元的经济损失。新城疫也被认为是一种经济代价高昂的疾病,给出口家禽产品的发展中国家的农民造成巨大的生产损失。 2021 年 10 月发表的《国际当代微生物学与应用科学杂志》(IJCMAS)报告显示,所有 25 家商业肉鸡农场因新城疫死亡造成的总损失和活禽总支出分别在 17,864 印度卢比(214.0 美元)至 2,66,080 印度卢比(3,188.89 美元)和 2,78,393 印度卢比(3,336.46 美元)至 17,86,745 印度卢比(21,413.6 美元)之间。此外,由于感染,各个农场活禽销售收入从 1,60,255 印度卢比(1,920.61 美元)到 12,46,314 印度卢比(14,936.7 美元)不等。

因此,家禽疾病发病率的上升,造成巨大的经济损失,增加了对家禽疫苗的需求,从而推动了市场的发展。

家禽疫苗市场概况

印度占亚太地区第二大市场份额。印度在全球家禽疫苗市场占有相当大的地位。家禽业的经济重要性可以根据印度家禽业占全国 GDP 的约 0.7% 和畜牧业 GDP 的 10% 来估计。最近,印度家禽业频繁遭受新型家禽疾病的侵袭,例如禽流感 (Avian Influenza,简称 AI),给印度和全球家禽业造成了巨大损失。禽流感已成为该国家禽业的一个不可预测的威胁,在过去十年中造成了 176 多起疫情,给家禽业造成了巨大的经济损失。每一起 AI 疫情都会导致国内需求扭曲,从而导致价格和全球贸易扭曲。迫切需要采取科学干预措施来遏制此类新兴家禽疾病在该国的危害。然而,目前的做法并未将禽流感疫苗纳入常规疫苗接种计划。因此,需要一种预测分析方法来预测疫情,更重要的是,开发出一种安全有效的禽流感疫苗。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

家禽疫苗市场:

家禽疫苗市场
  • Poultry Vaccines Market
    复合年增长率(2023 - 2031)
    8.6%
  • 2023 年市场规模
    21 亿美元
  • 2031 年市场规模
    41 亿美元

市场动态

增长动力
  • 家禽疾病发病率上升
未来的趋势
  • 载体疫苗和联合疫苗的进展
机会
  • 政府支持大规模疫苗接种活动和创新计划

关键人物;主力;重要一员

  • 勃林格殷格翰国际有限公司,
  • 硕腾公司,
  • 生物真空,
  • Phibro 动物保健,
  • 海丝特生物科学有限公司
  • Venky's(印度)有限公司,
  • Dechra Pharmaceuticals PLC,
  • Elanco 动物保健公司
  • 默克集团
  • 塞瓦,

区域概况

Poultry Vaccines Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Poultry Vaccines Market类型
  • 肉鸡
Poultry Vaccines MarketMate科技
  • 减毒活疫苗
  • 灭活疫苗
  • 重组疫苗
Poultry Vaccines Market剂型
  • 液体疫苗
  • 冻干疫苗
  • 粉状疫苗
Poultry Vaccines Market疾病
  • 禽流感
  • 禽沙门氏菌病
  • 马立克氏病
  • 传染性支气管炎
  • 传染性法氏囊病
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

家禽疫苗市场驱动因素和机遇

载体疫苗和联合疫苗的进展

载体疫苗的工作原理与传统疫苗不同,具有多种优势。这些优势包括无不良反应/反应、克服母体抗体干扰、应对不断发展的疾病挑战等。“Vaxxitek HVT+IBD+ND”是勃林格殷格翰生产的载体疫苗的一个例子,于 2019 年在美国上市。它是一种三价疫苗,可有效对抗三种疾病:马立克氏病 (MD)、传染性法氏囊病 (IBD) 和新城疫 (ND)。此外,2020 年,第二种三价疫苗“Vaxxitek HVT+IBD+ILT”在美国获得上市许可,用于预防 MD、IBD 和传染性喉气管炎 (ILT)。这些都是影响全球家禽业的高度传染性和商业破坏性疾病,而 Vaxxitek 被证明有助于一针战胜此类疾病。除勃林格殷格翰外,其他生产此类二价和三价疫苗的制造商将增加全球需求。此外,主要制造商计划采购五联疫苗,这将有助于克服家禽疾病并帮助他们在全球市场中脱颖而出。因此,载体疫苗和联合疫苗生产的进步是一种新趋势,可能会在未来几年推动家禽疫苗市场的增长。

政府支持大规模疫苗接种活动和创新计划

随着全球疾病负担 (GBD) 不断上升,世界各国政府都支持反对家禽疫苗接种。这些支持包括启动大规模疫苗接种计划以及在疫苗接种中心或通过上门免疫服务开展多项疫苗接种计划。

  • 2022 年 12 月,印度政府宣布启动“牲畜健康与疾病控制计划”等计划,通过实施针对多种疾病的预防性疫苗接种计划来改善动物健康部门。该计划由中央或各州推动,资金分配模式为 60:40。此外,该计划还涵盖 100% 由中央资助的“研究与创新、宣传与意识、培训和相关活动”。
  • 2023年4月,法国政府宣布通过招标,订购8000万剂禽流感疫苗,该国正准备开展大规模疫苗接种计划。法国“禽流感”部是欧盟(EU)第一个启动此类大规模疫苗接种计划的国家。为了开展如此大规模的疫苗接种活动,法国委托两家公司——法国诗华动物保健公司和德国勃林格殷格翰公司——开发禽流感疫苗。这两家公司的两种疫苗都能有效地保护鸟类免受病毒侵害。

因此,政府对大规模疫苗接种活动的支持和创新方案的设计预计将为未来几年家禽市场的增长提供丰厚的机会。

家禽疫苗市场报告细分分析

有助于得出家禽疫苗市场分析的关键部分是类型、技术、剂型、疾病、给药途径和最终用户。

  • 根据类型,家禽疫苗市场分为肉鸡疫苗和蛋鸡疫苗。2023 年,肉鸡疫苗占据了较大的市场份额。
  • 根据技术,市场分为减毒活疫苗、灭活疫苗和重组疫苗。减毒活疫苗在 2023 年占据了最大的市场份额。
  • 就剂型而言,市场分为液体疫苗、冻干疫苗和粉状疫苗。液体疫苗在 2023 年占据了市场主导地位。
  • 就疾病而言,市场细分为禽流感、禽沙门氏菌病、马立克氏病、传染性支气管炎、传染性法氏囊病 (IBD)、新城疫等。禽流感细分市场在 2023 年占据了市场主导地位。
  • 就给药途径而言,市场分为饮用水 (D/W)、肌肉注射 (I/M)、皮下注射 (I/S) 和其他。饮用水 (D/W) 部分在 2023 年占据了市场主导地位。
  • 就最终用户而言,市场分为家禽养殖场、兽医医院和家禽疫苗接种中心及诊所。家禽养殖场在 2023 年占据了市场主导地位。

家禽疫苗市场份额按地区分析

家禽疫苗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

亚太地区占据家禽疫苗市场的主导地位,预计未来几年将以最高的复合年增长率增长。在亚太地区,中国在 2022 年占据家禽疫苗市场的最大份额。中国正在经历快速的经济增长和城镇化。中国拥有该地区的主要医疗保健系统之一。该国市场的增长可以归因于对禽肉的需求不断增长、动物源性食品消费量不断增加、牲畜数量不断增加、对动物健康的认识不断提高以及中国家禽疾病爆发频率不断上升。因此,政府采取有利举措推动中国民众接种疫苗是影响家禽疫苗市场增长的关键因素。

家禽疫苗市场报告范围

报告属性细节
2023 年的市场规模21亿美元
2031 年市场规模41亿美元
全球复合年增长率(2023 - 2031)8.6%
历史数据2021-2022
预测期2023-2031
涵盖的领域按类型
  • 肉鸡
作者:MateTechnology
  • 减毒活疫苗
  • 灭活疫苗
  • 重组疫苗
按剂型
  • 液体疫苗
  • 冻干疫苗
  • 粉状疫苗
按疾病分类
  • 禽流感
  • 禽沙门氏菌病
  • 马立克氏病
  • 传染性支气管炎
  • 传染性法氏囊病
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 勃林格殷格翰国际有限公司,
  • 硕腾公司,
  • 生物真空,
  • Phibro 动物保健,
  • 海丝特生物科学有限公司
  • Venky's(印度)有限公司,
  • Dechra Pharmaceuticals PLC,
  • Elanco 动物保健公司
  • 默克集团
  • 塞瓦,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

家禽疫苗市场新闻和最新发展

家禽疫苗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是家禽疫苗市场的发展和策略列表:

  • 2021年4月,全球动物保健领导者勃林格殷格翰宣布在欧盟国家和英国推出下一代马立克氏病疫苗Prevexxion RN和Prevexxion RN+HVT+IBD。(来源:勃林格殷格翰,新闻稿,2021年)

家禽疫苗市场报告覆盖范围和交付成果

“家禽疫苗市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST 和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the poultry vaccines market?

The poultry vaccines market majorly consists of the players such Boehringer Ingelheim International GmbH, Zoetis, Inc., Biovac, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's India Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc, Merck KgaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB, and amongst others.

Which route of administration held the largest share in the poultry vaccines market?

The Drinking Water (D/W) segment dominated the global poultry vaccines market and held the largest market share in 2023.

What is the market CAGR value of poultry vaccines market during forecast period?

The CAGR value of the poultry vaccines market during the forecasted period of 2023-2031 is 8.6%.

Which disease indication segment leads the poultry vaccines market?

The Avian Influenza segment held the largest share of the market in the global poultry vaccines market and held the largest market share in 2023.

What is poultry vaccines?

The poultry industry constitutes a significant sector of world agriculture. In the US, more than 8 billion birds are produced annually with a value exceeding US$ 20 billion. Therefore, with rising poultry industry, demand for vaccination is an integral part of flock health management protocols. Therefore, disease prevention is an integral part of flock health management protocols.

What are the driving factors for the poultry vaccines market across the globe?

Key factors that are driving the growth of this market are rising prevalence of poultry diseases and growing poultry industry are expected to boost the market growth for the poultry vaccines over the years.

Which region is expected to witness significant demand for poultry vaccines market in the coming years?

Global poultry vaccines market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. Asia Pacific held the largest market share of the poultry vaccines market in 2023.

Which are the top companies that hold the market share in poultry vaccines market?

Zoetis Inc. and Boehringer Ingelheim are the top two companies that hold huge market shares in the poultry vaccines market.

The List of Report Companies - Poultry Vaccines Market

  1. Boehringer Ingelheim International GmbH
  2. Zoetis, Inc.
  3. Biovac
  4. Phibro Animal Health Corp
  5. Hester Biosciences Ltd
  6. Venky's India Ltd.
  7. Dechra Pharmaceuticals Plc
  8. Elanco Animal Health Inc
  9. Merck KgaA
  10. Ceva
  11. Nisseiken Co Ltd
  12. Vaccinova AB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..